Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1165-1171

  Maluf, F C ^a   Leiser, A L ^a   Aghajanian, C ^a   Sabbatini, P ^a   Pezzulli, S ^a   Chi, D S ^a   Wolf, J K ^b   Levenback, C ^b   Loh, E ^c   Spriggs, D R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Sanofi Winthrop Inc   (United States)

Author keywords

Cervical cancer; Cisplatin; Tirapazamine

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; LORAZEPAM; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN ANTAGONIST; TIRAPAZAMINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG FATALITY; DRUG FEVER; DRUG INFUSION; DRUG TOLERABILITY; DYSTONIA; EVALUATION; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOCYTOPENIA; HEARING LOSS; HUMAN; HYPOMAGNESEMIA; LUNG EMBOLISM; NAUSEA; OTOTOXICITY; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SAMPLE SIZE; SIDE EFFECT; THERAPY EFFECT; TINNITUS; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; AGRANULOCYTOSIS; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUTROPENIA; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TRIAZINES; UTERINE CERVICAL NEOPLASMS;

EID: 33745079932     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00454.x     Document Type: Article

References (32)

1. Morris M Blessing JA Monk BJ McGehee R Moore DH. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004 22 : 3340 4.
2. Fiorica JV. The role of topotecan in the treatment of advanced cervical cancer. Gynecol Oncol 2003 90 ( Pt 2 S16 21.
3. Long HJ III. Bundy BN Grendys EC Jr. et al. Abstracts presented for the 35th Annual Meeting of the Society of Gynecologic Oncologists, Randomized phase III trial of cisplatin vs. cisplatin plus topotecan vs. MVAC in stage IVB, recurrent or persistent carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 2004 92 : 397.
4. Brader KR Morris M Levenback C Levy L Lucas KR Gershenson DM. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 1998 16 : 1879 84.
5. Thigpen T Vance RB Khansur T. Carcinoma of the uterine cervix: current status and future directions. Semin Oncol 1994 21 ( Suppl. 2 43 54 quiz 55, 58.
6. Brown JM. The hypoxic cell: a target for selective cancer therapy - eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999 59 : 5863 70.
7. Rauth AM Melo T Misra V. Bioreductive therapies: an overview of drugs and their mechanisms of action. Int J Radiat Oncol Biol Phys 1998 42 : 755 62.
8. Dorie MJ Brown JM. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin. Cancer Res 1993 53 : 4633 6.
9. Brown JM. Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine. Br J Cancer 1998 77 ( Suppl. 4 12 4.
10. Siemann DW Hinchman CA. Potentiation of cisplatin activity by the bioreductive agent tirapazamine. Radiother Oncol 1998 47 : 215 20.
11. von Pawel J von Roemeling R Gatzemeier U et al. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the international CATAPULT I study group. Cisplatin and tirapazamine in subjects with advanced previously untreated non-small-cell lung tumors. J Clin Oncol 2000 18 : 1351 9.
12. Johnson CA Kilpatrick D von Roemeling R et al. Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors. J Clin Oncol 1997 15 : 773 80.
13. Rischin D Peters L Hicks R et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol 2001 19 : 535 42.
14. Bedikian AY Legha SS Eton O et al. Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma. Anticancer Drugs 1999 10 : 735 9.
15. Rischin D Peters L Fisher R et al. Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 2005 23 : 79 87.
16. Craighead PS Pearcey R Stuart G. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2000 48 : 791 5.
17. Del Rowe J Scott C Werner-Wasik M et al. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. J Clin Oncol 2000 18 : 1254 9.
18. Aghajanian C Brown C O'Flaherty C et al. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer. Gynecol Oncol 1997 67 : 127 30.
19. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989 10 : 1 10.
20. Tambaro R Scambia G DiMaio M et al. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer. Crit Rev Oncol Hematol 2004 52 : 33 44.
21. Bonomi P Blessing JA Stehman FB DiSaia PJ Walton L Major FJ. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985 3 : 1079 85.
22. Burnett AF Roman LD Garcia AA Muderspach LI Brader KR Morrow CP. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000 76 : 63 6.
23. Hempling RE Eltabbakh GH Piver MS Recio FO O'Neill CP. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma. Am J Clin Oncol 1997 20 : 315 8.
24. Omura GA Blessing JA Vaccarello L et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997 15 : 165 71.
25. Papadimitirou CA Sarris K Moulopoulos LA et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 1999 17 : 761 6.
26. Rose PG Blessing JA Gershenson DM McGehee R. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 1999 17 : 2676 80.
27. Moore DH Blessing JA McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004 22 : 3113 9.
28. Brown JM. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br J Cancer 1993 67 : 1163 70.
29. Gatzemeier U Rodriguez G Treat J et al. Tirapazamine-cisplatin: the synergy. Br J Cancer 1998 77 ( Suppl. 4 15 7.
30. Thigpen JT Blessing JA DiSaia PJ Fowler WC Jr. Hatch KD. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a gynecologic oncology group study. Gynecol Oncol 1989 32 : 198 202.
31. Miller VA Ng KK Grant SC et al. Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol 1997 8 : 1269 71.
32. Treat J Johnson E Langer C et al. Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 1998 16 : 3524 7.